# Open Label Pharmaco- Magnetic Resonance Spectrography (MRS) Study of Clavulanic Acid

> **NCT03986762** · PHASE1 · COMPLETED · sponsor: **Temple University** · enrollment: 9 (actual)

## Conditions studied

- Cocaine Dependence, in Remission
- Cocaine Abuse, in Remission
- Cocaine-Related Disorders

## Interventions

- **DRUG:** Clavulanic Acid

## Key facts

- **NCT ID:** NCT03986762
- **Lead sponsor:** Temple University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-12
- **Primary completion:** 2019-12-20
- **Final completion:** 2019-12-20
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2020-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03986762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03986762, "Open Label Pharmaco- Magnetic Resonance Spectrography (MRS) Study of Clavulanic Acid". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03986762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*